Skip to main content

Table 5 Factors associated with HBV screening during one’s lifetime and anti-HBV vaccination, KABP survey, France, 2010 (multivariate analysis)

From: Hepatitis B knowledge, perceptions and practices in the French general population: the room for improvement

  HBV screening Anti-HBV vaccination
% Adjusted OR CI 95% % Adjusted OR CI 95%
Gender       
 Men 27.1 1   45.1 1  
 Women 27.8 0.95 0.9-1.1 48.9 1.2 1.1-1.3
Age (in years)       
 18–30 26.0 1   62.3 1  
 31–44 32.6 1.3 1.2-1.5 54.5 0.7 0.6-0.7
 45–54 26.5 1.2 0.97-1.4 36.4 0.3 0.3-0.4
 55-69 21.7 1.1 0.9-1.3 27.4 0.2 0.2-0.3
Educational level       
 No educational qualification 18.2 1   33.7 1  
 CAP/BEP/BEPC (vocational diplomas) 23.4 1.4 1.04-1.6 41.3 1.1 0.9-1.3
 Secondary school certificate 26.1 1.5 1.1-1.8 49.5 1.2 1.01-1.5
 Higher education qualification 34.2 1.8 1.5-2.3 54.4 1.5 1.2-1.8
Net monthly income per household       
 <2,000 € 25.6 1   45.8 1  
 2,000–2,999 € 26.6 0.9 0.8-1.1 47.4 1.0 0.9-1.2
 ≥ 3,000 € 30.4 0.9 0.8-1.1 48.2 1.0 0.9-1.2
 Did not wish to share this information/ Did not know 16.2 0.6 0.4-0.9 40.5 0.9 0.6-1.3
Area of residence       
 Outside the Ile-de-France administrative district 26.2 1   46.1 1  
 Ile-de-France administrative district (which includes Paris) 32.5 1.2 1.04-1.3 50.9 1.0 0.9-1.2
Living in a couple or a stable relationship       
 No 25.4 1   48.0 1  
 Yes 28.1 1.1 0.98-1.3 46.8 1.0 0.9-1.2
Knowing someone in circle of family and friends who was infected       
 No 23.7 1   46.5 1  
 Yes 41.1 2.1 1.9-2.4 49.0 1.0 0.9-1.2
Having a good level of knowledge about HBV transmission modes       
 No 23.9 1   44.3 1  
 Yes 33.6 1.4 1.3-1.6 51.7 1.1 0.97-1.2
Perception of being at greater risk of HBV infection with respect to the average person      
 No 25.6 1   45.5 1  
 Yes 50.1 2.5 2.1-3.1 66.1 2.2 1.8-2.7
HBV endemicity in country of birth1       
 Low 26.8 1   46.8 1  
 Intermediate 30.1 1.2 0.9-1.4 47.3 1.1 0.9-1.4
 High 45.1 2.1 1.5-2.9 56.1 1.2 0.8-1.6
Intravenous drug use in one’s lifetime       
 No 27.4 1   47.0 1  
 Yes 45.6 2.2 1.2-4.2 52.1 1.2 0.6-2.4
HBV screening during one’s lifetime       
 No - - - 40.3 1  
 Yes     64.8 2.4 2.2-2.7
Anti-HBV vaccination       
 No 18.3 1   - - -
 Yes 37.8 2.4 2.2-2.7    
  1. 95% CI: 95% confidence interval.
  2. 1 See the footnote in Table 1 .